Extract

Background and study aims A hip fracture is where there is a break in the upper thigh bone (femur). They are very common, particularly in older adults, and are extremely painful. A nerve block is a type of treatment in which a local anaesthetic (numbing) fluid is injected into the area that is painful in order to relieve pain. A Fascia Iliaca Compartment Block (FICB) is a type of nerve block in which the anaesthetic is injected into the space below the layer of muscle at the top of the leg. This study evaluates whether the use of a relative new way of administering this injection called a supra-inguinal FICB. This is where the anaesthetic is injected above the inguinal ligament (band of tissue in the groin) in order to decrease the need for morphine-like pain medications. Who can participate? Adults with a broken hip. What does the study involve? All participants receive pain management treatment with a supra-inguinal FICB. Each participant is asked to rate their pain with a number on a scale of 0 (no pain) to 10 (most severe pain imaginable) before the injection and then 30, 60 and 120 minutes afterwards. Participants are assessed and reviewed by the medical staff so that their need for other pain medication (and what they had already been given), side effects and type of hip fracture can be recorded. Data from these patients is compared with data from the hip fracture patients who do not receive this nerve block, during the same study period. What are the possible benefits and risks of participating? There are no direct benefits or risks involved with participating, as the study does not change the treatment participants receive as part of their standard care. Where is the study run from? Academic Medical Center (Netherlands) When is the study starting and how long is it expected to run for? January 2014 to July 2015 Who is funding the study? Academic Medical Center (Netherlands) Who is the main contact? Mr Milan Ridderikhof [email protected]

Inclusion criteria

• Hip Fracture

Links

• isrctn
• ictrp